Table 5.
Patient count | LD | Normalized | p |
---|---|---|---|
Hydroxychloroquine (+) | 37 | 32 | 0.90 |
Hydroxychloroquine (−) | 53 | 44 | |
Mycophenolic mofetil (+) | 14 | 12 | 0.97 |
Mycophenolic mofetil (−) | 76 | 64 | |
Mycophenolic acid (+) | 3 | 2 | 0.79 |
Mycophenolic acid (−) | 87 | 74 | |
Azathioprine (+) | 7 | 7 | 0.74 |
Azathioprine (−) | 83 | 69 | |
Prednisone (+) | 41 | 47 | 0.043 |
Prednisone (−) | 49 | 29 | |
Methotrexate (+) | 5 | 3 | 0.63 |
Methotrexate (−) | 85 | 73 | |
Cyclophosphamide (+) | 2 | 3 | 0.52 |
Cyclophosphamide (−) | 88 | 73 | |
Cyclosporine (+) | 4 | 6 | 0.75 |
Cyclosporine (−) | 85 | 83 | |
Rapamycin (+) | 0 | 2 | 0.155 |
Rapamycin (−) | 90 | 88 | |
N-acetylcysteine (+) | 0 | 1 | 1.00 |
N-acetylcysteine (−) | 90 | 89 | |
Rituximab (+) | 0 | 0 | NA |
Rituximab (−) | 90 | 76 | |
Anti-TNF (+) | 1 | 0 | 0.36 |
Anti-TNF (−) | 89 | 76 | |
NSAIDs (+) | 23 | 12 | 0.12 |
NSAIDs (−) | 67 | 64 |